Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-18

Clinical Trial Update: STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss [Phase 4]

View source ↗

Summary

Phase 4 research study sponsored by Novo Nordisk A/S evaluating whether semaglutide helps adolescents with obesity lose weight and maintain the loss; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (Wegovy) (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 4 | Status: ACTIVE_NOT_RECRUITING